Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-09-13 00:00:00 ET · period of report 2024-09-12 · accession 0001946439-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-13 | 2024-09-12 | ANIP | Davis Krista | SVP, Chief HR Off | F - Tax | $56.15 | -1,486 | 50.1K | -3% | -$83.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | F | D | 1,486 | $56.15 | 50,059 | D | — | — |